The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown.
An individualized neoantigen mRNA vaccine was tested in patients with early-stage triple-negative breast cancer and showed feasibility, safety, and strong T cell immune responses. Long-term follow-up ...
The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown. Researchers at the University Hospital ...
The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown. Researchers at the University Hospital ...
ImmunityBio, Inc. (NYSE: IBRX), a commercial stage immunotherapy company developing next generation therapies that drive immunological memory and restore immune competence, today announced that the ...
University of Pennsylvania Perelman School of Medicine and Yale University School of Medicine, along with other collaborators, report that lung adenocarcinoma can engage nerve pathways that link the ...
new video loaded: According to Vance, ICE Officers No Longer Have ‘Absolute Immunity’ transcript The precedent here is very simple. You have a federal law enforcement official engaging in federal law ...
MinnPost’s journalists are out in the community to report on the things that are happening in Minnesota. Your support right now will help fund their work AND keep our news paywall-free. Federal ...
1Department of Translational Dental Medicine, Boston University Henry M. Goldman School of Dental Medicine, Boston, Massachusetts.
It’s among the most-contagious viruses known. One infection can be expected to spread to between 12 and 18 additional people. If 10 unvaccinated people are in a room with a known case, nine will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results